YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination

View at publisher Summarise with VIRAT
Authors: James William Smithy, Victoria Ciallella, Claire N. Thant, Hannah L. Kalvin, Jaykumar Ranchodbhai Thumar, Suresh Nair, Alexander Noor Shoushtari, Parisa Momtaz, Monica F. Chen, Katherine S. Panageas, Benjamin D. Greenbaum, Neeman Mohibullah
+1 more Michael Andrew Postow
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Cutaneous Melanoma Detection and Management

Publication details

Journal / source
Journal of the National Comprehensive Cancer Network
Volume
24
Issue
3.5
Publication date
27 March 2026
Language
EN